Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis

• المؤلفون الرئيسيون: Daniel Sánchez-Cano (مؤلف), José Luis Callejas-Rubio (مؤلف), Ricardo Ruiz-Villaverde (مؤلف), Raquel Ríos-Fernández (مؤلف), Norberto Ortego-Centeno (مؤلف)
• التنسيق: كتاب
• منشور في: Hindawi Limited, 2013-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Tumoral necrosis factor α plays a central role in both the inflammatory response and that of the immune system. Thus, its blockade with the so-called anti-TNF agents (infliximab, etanercept, adalimumab, certolizumab pegol, and golimumab) has turned into the most important tool in the management of a...